News

A patented, broad-spectrum liquid chemical warfare (CW) agent decontaminant, RSDL neutralizes or removes CW agents and T2 toxin from skin on contact, leaving a non-toxic residue that can

Under the terms of the agreement, the company is entitled to receive a payment of E3 million from Merck KGaA, the global pharmaceutical and chemical company based in

Imprime PGG is a targeted immunotherapeutic drug candidate from Biothera that works synergistically with monoclonal antibodies through specific innate immune cell activation. Erbitux is an anti-tumor monoclonal antibody

The company said that it is also investigating other novel and generic drugs and promising therapeutic areas in combination with using its patented transdermal delivery system. Juliet Singh,

The Serdaxin Phase IIa study calls for the recruitment of up to 100 patients to evaluate its preliminary efficacy in treating major depressive disorder. Rexahn’s Phase IIa clinical

In this role, Dr Cheng will be responsible for Gilead’s biometrics, clinical operations, drug safety and public health, project and portfolio management, and regulatory affairs activities, reporting to

Robin Carlstein, senior vice president of advanced wound devices at Smith & Nephew, said: “Smith & Nephew welcomes the appeals court decision that our Versatile 1 negative pressure

This device-based intellectual property has not been used to date in the Celacade System; however, Vasogen has retained rights to this technology for any potential use as it

Since 1998, Dr Morra has been a board member and consultant for various public and private life science companies. Dr Morra has previously served as the president of